| 1.8 |
5.4 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 1.0 |
2.9 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) negative regulation of urine volume(GO:0035811) regulation of renin secretion into blood stream(GO:1900133) |
| 0.7 |
4.9 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.7 |
2.0 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.4 |
1.3 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.4 |
1.2 |
GO:0010751 |
regulation of arginine metabolic process(GO:0000821) negative regulation of nitric oxide mediated signal transduction(GO:0010751) negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.4 |
1.9 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.4 |
2.3 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.4 |
2.9 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.3 |
2.0 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.3 |
2.8 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.3 |
3.8 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.2 |
0.7 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.2 |
1.6 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.2 |
1.9 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.4 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) aggrephagy(GO:0035973) |
| 0.1 |
0.4 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
| 0.1 |
0.4 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
1.8 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 |
1.2 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
1.2 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 |
0.4 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 |
0.5 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
4.0 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.3 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
0.4 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 0.1 |
1.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.3 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.1 |
0.1 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.1 |
0.3 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.1 |
0.5 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.5 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.7 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.4 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
0.4 |
GO:0090164 |
protein retention in Golgi apparatus(GO:0045053) asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
1.1 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.4 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
1.6 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
0.9 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
0.5 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
0.2 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.1 |
0.7 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.2 |
GO:2000832 |
cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.1 |
0.2 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.1 |
1.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.4 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.3 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.1 |
0.7 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.4 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.2 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
0.4 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.3 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.0 |
0.4 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.0 |
0.2 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
2.0 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 |
7.9 |
GO:0007219 |
Notch signaling pathway(GO:0007219) |
| 0.0 |
1.4 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
2.5 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.2 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.0 |
0.3 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 |
0.2 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.3 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 |
1.1 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.0 |
0.4 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.0 |
0.3 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.3 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.5 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.0 |
0.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.6 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.0 |
0.3 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.4 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.0 |
0.5 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.2 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.0 |
0.1 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 |
0.5 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
2.6 |
GO:0000077 |
DNA damage checkpoint(GO:0000077) |
| 0.0 |
1.0 |
GO:0006418 |
tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 |
0.8 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.3 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.7 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
2.0 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.0 |
0.1 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 |
0.6 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
0.8 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.1 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.5 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.0 |
0.2 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.0 |
0.8 |
GO:0000086 |
G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.0 |
0.2 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.0 |
0.9 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
